MediHerb, Quality Herbal Supplements Distributed by Standard Proces Inc.
Research Objectives
Ultraviolet-visible spectrophotometers are routinely used in MediHerb's herbal analysis
The research group at MediHerb is committed to the development of efficacious herbal therapies. This involves three major areas of focus, which are all interconnected:
- Formulation of efficacious herbal solutions to meet patients' needs
- Validating the efficacy of herbal formulas by clinical trials and in vitro research
- Researching the phytochemistry of medicinal plants
It is by combining phytochemical, biochemical, clinical and traditional herbal knowledge that MediHerb can continue to produce high quality products, which meet the changing needs of the market.
The MediHerb Research Laboratory is well equipped with gas chromatographs (GC), thin layer chromatography (TLC), ultraviolet-visible (UV-Vis) spectrophotometers, high performance thin layer chromatography (HPTLC), and high performance liquid chromatographs (HPLC). The HPLCs are equipped with photo diode array (PDA), evaporative light scattering detectors (ELSD) and sophisticated mass spectrometer (MS) detectors. Access to nuclear magnetic resonance (NMR) and infra-red (IR) spectrometers, polarimeters, gas chromatographs with mass spectrometer detection, and HPLC with MS/MS capabilities is available on campus.
The Research and Development team works closely with herbal and naturopathic clinicians within the company and with a board of leading Australian and international clinicians on product development. This ensures that MediHerb has taken the best of science, traditional knowledge and current clinic al knowledge to make the most efficacious herbal solutions relevant to your clinical practice.
New Product Development Process
MediHerb has implemented a rigorous new product development process, which ensures that the appropriate steps are undertaken when investigating the introduction of new products into our product line. By reviewing all the relevant information available regarding the therapeutic outcome, we are seeking to develop a short list of key herbs which are then subjected to closer analysis. This involves detailed examination of the:
- Clinical outcomes
- Phytochemistry
- Analytical methodology
- Continuity of supply
- Economic sustainability
- Synergy of the final formula
- Cost to the patient
- Practicality of final dose formulation
Once the prototype formulation is agreed upon, MediHerb undertakes a controlled human trial to prove the efficacy and safety of the product. This may either be a full clinical trial or may be an open trial in conjunction with our experienced clinicians. Products with well documented evidence of traditional use are often subjected to the feedback trial. For more novel formulations that do not have significant traditional use, a full clinical trial evaluation is performed.